Takeaways from this week in optometry: April 28 - May 2
Catch up on the top stories in optometry during the week of April 28-May 2.
Topcon Healthcare acquires RetInSight to fuel AI in retinal disease diagnosis, monitoring
With the acquisition, Topcon Healthcare also assumes RetInSight’s AI algorithms that analyze retinal images to detect and monitor disease.
ARVO 2025: New research reveals new marker for presbyopic accommodation
While the study included a range of subjects in a variety of stages of presbyopia, the change in crystalline lens geometry and anterior segment was most pronounced in emmetropic and myopic presbyopes.
SightGlass Vision studies find DOT spectacle lenses as highly effective for myopia management, show no evidence of rebound
The CATHAY trial evaluated 186 myopic children, 6 to 13 years old at initiation, across 5 hospitals.
The contact lens follow-up factor: The full conversation with Drs Brianna Rhue and Diana Canto-Sims
Rhue and Canto-Sims tackle the problem of many optometry practices losing significant revenue due to ineffective follow-up systems.
18-month data of IOL-mounted drug delivery platform shows impressive results in IOP, visual acuity
Results from the first-in-human study of SpyGlass Pharma's bimatoprost-eluting IOL showed significant reduction in IOP and improved best-corrected distance visual acuity.
UPTE-CWA 9119, AFSCME unions cite UC's "unfair labor practices" in May 1 strikes
The strikes follow the University of California’s hiring freeze implemented on March 19.
FDA grants clearance of OcuMet Beacon, a noninvasive tool for assessing retinal health
The company said it will be available on the US market for use in clinics and healthcare institutions.
ASCRS 2025: A noninvasive approach to blepharoplasty reduces recovery time, bruising
A closer look at periorbital allergic dermatitis
Identifying allergens or irritants can be challenging, but a few strategies can help patients find relief.
ASCRS 2025: Recognizing and managing neurotrophic keratitis with cryopreserved amniotic membrane
An emerging treatment approach for a commonly underdiagnosed ocular surface disease.
Does alcohol affect macular degeneration?
FDA clears expansion of Luminopia amblyopia treatment to include 8 to 12 year old patients
This expansion marks the first FDA clearance for an amblyopia treatment for this age range in more than 2 decades.
ASCRS 2025: Enhancing patient outcomes with presbyopia-correcting IOLs
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
University of Cincinnati researchers find fear of vision loss may be deterring patients from cataract surgery
Of participants surveyed, 36% reported a fear of cataract surgery, with more than half of those specifically feared it would lead to vision loss.
iSTAR Medical announces positive 5-year data from its STAR-GLOBAL trial for supraciliary MIGS device
STAR-GLOBAL is an extension trial of the initial EU clinical trials investigating the long term safety and efficacy of MINIject in patients with up to 5 years of follow up.
The contact lens follow-up factor: A conversation with Drs Brianna Rhue and Diana Canto-Sims – Part 2
Rhue and Canto-Sims talk about the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Nordic Pharma partners with Harrow to launch an authorized generic of Maxitrol
Maxitrol has been the leading corticosteroid/antibiotic combination drop for the treatment of ocular inflammation and bacterial infections for more than 50 years.
ASCRS 2025: EVO ICL in low to moderate myopia may rival LASIK
Eva Kim, MD, offers valuable insights into why EVO ICL is becoming a compelling alternative to traditional corneal procedures like LASIK.
Focus Vitamins expands portfolio with new Focus Lutein Capsules
The optimal triple-carotenoid supports daily eye health with lutein, zeaxanthin, and meso-zeaxanthin, according to the company.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Boy wearing DOT lenses with family in background Image credit: SightGlassVision")
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "The contact lens follow-up factor: The full conversation with Drs Brianna Rhue and Diana Canto-Sims")
